MetLife Investment Management’s Amdocs DOX Stock Holding History
Bought
Maintained
Sold
Other funds holding DOX
BGC
BIP
VPM
MetLife Investment Management's DOX Position: Q1 2026 in Review
MetLife Investment Management reduced its Amdocs (DOX) stake by 1.7% in Q1 2026, selling an estimated $2.27K and leaving 1,741 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #2481.
MetLife Investment Management first reported a position in DOX in Q3 2018 and has held it in 20 quarters since. The position peaked at $236K in Q1 2023. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.
- MetLife Investment Management held 1,741 shares of Amdocs worth $114K as of Q1 2026.
- MetLife Investment Management sold 31 Amdocs shares in Q1 2026, an estimated $2.27K.
- Amdocs made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2481 holding.
- MetLife Investment Management first reported a position in Amdocs in Q3 2018 and has held it in 20 quarters since.
- MetLife Investment Management's Amdocs position peaked at $236K in Q1 2023.
- 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.